医疗保险D部分：患者承担“仿制药”品牌药的费用。
Medicare Part D: Patients Bear The Cost Of 'Me Too' Brand-Name Drugs.
作者信息
Gastala Nicole M, Wingrove Peter, Gaglioti Anne, Petterson Stephen, Bazemore Andrew
机构信息
Nicole M. Gastala (
Peter Wingrove is a research analyst at the Robert Graham Center for Policy Studies.
出版信息
Health Aff (Millwood). 2016 Jul 1;35(7):1237-40. doi: 10.1377/hlthaff.2016.0146.
PMID:27385239
Abstract
Prescription drugs are a major source of US health care expenditure. "Me too" brand-name medications contribute to the cost of drugs, which is substantial for consumers. In 2013 patient copayments averaged 10.5 times more for two commonly prescribed brand-name medications versus generic therapeutic alternatives.
摘要
处方药是美国医疗保健支出的主要来源。仿制药增加了药品成本，这对消费者来说是一笔不小的开支。2013年，患者针对两种常用处方药的自付费用平均比对通用治疗替代药物高出10.5倍。
Zotero 插件